I am a
Home I AM A Search Login

Papers of the Week


Papers: 22 Oct 2022 - 28 Oct 2022


Pharmacology/Drug Development


2022 Oct 27


Pain Pract

Gabapentin-Friend or foe?

Authors

Russo M, Graham B, Santarelli DM
Pain Pract. 2022 Oct 27.
PMID: 36300903.

Abstract

Gabapentin is a recommended first-line agent for treating neuropathic pain; however, its efficacy rate is reportedly low, and the risk of adverse events is high. A plausible explanation for this lies with its wide range of actions, the entirety of which have yet to be fully elucidated.